Teriparatid Pliva

Teriparatide Pliva is a parathyroid hormone analog prescribed for osteoporosis management. This injectable medication supports bone density and reduces fracture risk in adults. Suitable for postmenopausal women and men at high risk. Always follow healthcare provider guidance for safe use.

Teriparatide Pliva is primarily used to treat osteoporosis in postmenopausal women and men who are at high risk for fractures. It works by stimulating bone formation, increasing bone mineral density, and reducing the likelihood of vertebral and non-vertebral fractures. This medication is often prescribed when other osteoporosis treatments have not been effective or are not tolerated.

Teriparatide Pliva helps rebuild bone tissue by encouraging the growth of new, stronger bone. Users may notice improved mobility and reduced pain associated with osteoporosis over time. The medication is administered via a prefilled pen for daily injections, typically in the thigh or abdomen. Consistent use is important to achieve the best results.

Store Teriparatide Pliva in the refrigerator but do not freeze. Protect it from light and keep it in the original packaging until use. Discard any unused medication after 28 days of first use. Always use a new needle for each injection and dispose of needles safely in a sharps container. Consult your healthcare provider if you experience persistent pain or swelling at the injection site.

Teriparatide Pliva may interact with digoxin, increasing the risk of high calcium levels in the blood. Avoid using other osteoporosis medications, such as bisphosphonates, while taking teriparatide unless directed by your doctor. Alcohol and tobacco may reduce the effectiveness of the treatment. Always inform your healthcare provider about all medications and supplements you are taking before starting teriparatide.